Why the study?
Does home monitoring of implantable cardioverter defibrillators reduce major adverse events compared to standard ambulatory follow-ups in patients with ICDs?
Population
433 patients with implantable cardioverter defibrillators (ICD)
Comparison
Home monitoring of ICD with ambulatory visits… vs Standard ambulatory follow-ups every 6 months
Design
RCT, randomly compare
Follow-up
24.2 months
Authors
Loading...
Home monitoring may safely reduce in-person ICD visits; confirms non-inferiority and extends remote care evidence in RCTs.
Does home monitoring of implantable cardioverter defibrillators reduce major adverse events compared to standard ambulatory follow-ups in patients with ICDs?
Home monitoring of ICDs is non-inferior to standard ambulatory follow-up for major adverse events and significantly reduces the number of appropriate and inappropriate shocks while sparing battery life.
Guédon-Moreau et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: